Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers

Details for Australian Patent Application No. 2008201044 (hide)

Owner Agensys, Inc.

Inventors Hubert, Rene S.; Morrison, Robert Kendall; Challita-Eid, Pia M.; Ge, Wangmao; Morrison, Karen; Jakobovits, Aya; Raitano, Arthur B.; Faris, Mary

Agent FB Rice

Pub. Number AU-B-2008201044

Parent 2002318112

Filing date 5 March 2008

Wipo publication date 3 April 2008

Acceptance publication date 28 July 2011

International Classifications

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

20 March 2008 Complete Application Filed

3 April 2008 Application Open to Public Inspection

  Published as AU-B-2008201044

28 July 2011 Application Accepted

  Published as AU-B-2008201044

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201045-Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction

2008201043-Stabilization of hypoxia inducible factor (HIF) alpha